Susan B. Ingersoll

Florida Hospital Cancer Institute

Papers

3

Total Citations

227

H-Index

2

About

Dr. Susan B. Ingersoll is a leading gynecologic oncologist whose research has fundamentally advanced the surgical staging of endometrial cancer, particularly through the optimization of sentinel lymph node mapping. Her work focuses on improving the accuracy and safety of minimally invasive procedures, with a specific emphasis on comparing different imaging modalities. Dr. Ingersoll’s landmark 2012 study, which has garnered over 155 citations, established a critical comparison between colorimetric and fluorescence imaging for detecting sentinel nodes during robotic-assisted staging. She further validated these findings through a prospective cohort study (70 citations), demonstrating the superior detection rates of fluorescent imaging. Her contributions have directly shaped clinical guidelines, enabling more precise cancer staging while reducing the morbidity associated with complete lymphadenectomy. By rigorously evaluating these technologies through prospective trials, Dr. Ingersoll has provided the evidence base for a paradigm shift in surgical practice, making her a pivotal figure in the evolution of personalized, less invasive care for women with endometrial cancer.

Research Focus

Key Achievements

2
H-Index
3
Papers
227
Total Citations
76
Avg Citations/Paper
🏆 Most Cited Paper
Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging
155 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Florida Hospital Cancer Institute

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago